Next Article in Journal
Prevalence and Outcomes Associated with Vitamin D Deficiency among Indexed Hospitalizations with Cardiovascular Disease and Cerebrovascular Disorder—A Nationwide Study
Previous Article in Journal
Hospital-Acquired Serum Ionized Calcium Derangements and Their Associations with In-Hospital Mortality
Previous Article in Special Issue
Natural Compounds as New Cancer Treatments
 
Search for Articles:
Title / Keyword
Author / Affiliation
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
Journals
Medicines
Volume 7
Issue 11
10.3390/medicines7110071
medicines-logo
Submit to this Journal Review for this Journal Edit a Special Issue
► Article Menu

Article Menu

Printed Edition

A printed edition of this Special Issue is available at MDPI Books....
share announcement thumb_up
...
textsms
...
Correction of Medicines 2019, 6(1), 2.
Open AccessCorrection

Correction: Oral Intake of Royal Jelly Has Protective Effects against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Trial. Medicines, 2019, 6, 2

by
Kyohei Araki
,
Yasuyoshi Miyata
*,
Kojiro Ohba
,
Yuichiro Nakamura
,
Tomohiro Matsuo
,
Yasushi Mochizuki
and
Hideki Sakai
Department of Urology, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, Nagasaki 852-8501, Japan
*
Author to whom correspondence should be addressed.
Medicines 2020, 7(11), 71; https://0-doi-org.brum.beds.ac.uk/10.3390/medicines7110071
Received: 19 October 2020 / Accepted: 19 October 2020 / Published: 19 November 2020
(This article belongs to the Special Issue Natural Compounds as New Cancer Treatments)
View Full-Text Download PDF

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

We, the authors, wish to make the following correction to our published paper [...] View Full-Text
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
SciFeed

Share and Cite

MDPI and ACS Style

Araki, K.; Miyata, Y.; Ohba, K.; Nakamura, Y.; Matsuo, T.; Mochizuki, Y.; Sakai, H. Correction: Oral Intake of Royal Jelly Has Protective Effects against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Trial. Medicines, 2019, 6, 2. Medicines 2020, 7, 71. https://0-doi-org.brum.beds.ac.uk/10.3390/medicines7110071

AMA Style

Araki K, Miyata Y, Ohba K, Nakamura Y, Matsuo T, Mochizuki Y, Sakai H. Correction: Oral Intake of Royal Jelly Has Protective Effects against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Trial. Medicines, 2019, 6, 2. Medicines. 2020; 7(11):71. https://0-doi-org.brum.beds.ac.uk/10.3390/medicines7110071

Chicago/Turabian Style

Araki, Kyohei; Miyata, Yasuyoshi; Ohba, Kojiro; Nakamura, Yuichiro; Matsuo, Tomohiro; Mochizuki, Yasushi; Sakai, Hideki. 2020. "Correction: Oral Intake of Royal Jelly Has Protective Effects against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Trial. Medicines, 2019, 6, 2" Medicines 7, no. 11: 71. https://0-doi-org.brum.beds.ac.uk/10.3390/medicines7110071

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop